123 related articles for article (PubMed ID: 28279886)
1. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.
Mahar AL; Kagedan DJ; Hallet J; Coburn NG
Breast; 2017 Jun; 33():34-37. PubMed ID: 28279886
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
3. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
Li CI; Anderson BO; Daling JR; Moe RE
JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
[TBL] [Abstract][Full Text] [Related]
5. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
6. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
7. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
[TBL] [Abstract][Full Text] [Related]
9. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.
Robinson D; Holmberg L; Møller H
Br J Cancer; 2008 Aug; 99(4):611-5. PubMed ID: 18665169
[TBL] [Abstract][Full Text] [Related]
10. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
[TBL] [Abstract][Full Text] [Related]
11. Synchronous and metachronous bilateral breast cancer: A long-term experience.
Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
[TBL] [Abstract][Full Text] [Related]
12. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
[TBL] [Abstract][Full Text] [Related]
13. Mammographic breast density is associated with the development of contralateral breast cancer.
Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
[TBL] [Abstract][Full Text] [Related]
14. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
15. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
[TBL] [Abstract][Full Text] [Related]
16. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
[TBL] [Abstract][Full Text] [Related]
18. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).
Murthy V; Pawar S; Chamberlain RS
Clin Breast Cancer; 2017 Aug; 17(5):392-398. PubMed ID: 28602452
[TBL] [Abstract][Full Text] [Related]
19. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
20. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?
Chikman B; Davidson T; Kais H; Jeroukhimov I; Leshno A; Sandbank J; Halevy A; Lavy R
Fam Cancer; 2016 Jan; 15(1):41-7. PubMed ID: 26358115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
